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ABSTRACT: Medicinal plants and natural products have many applications in 
the treatment of viral diseases, due to much lower side effects. Different types of 
hepatitis, especially hepatitis B, are of the viral diseases whose treatment using 
herbal medicines is currently of great interest due to the limited availability of 
effective chemical drugs and having numerous side effects. Due to the attention 
paid to herbal drugs and their importance for the treatment of hepatitis B, we 
conducted this review to take a look at the evidence regarding the action 
mechanisms of viruses, antiviral herbal remedies and various herbal anti-
hepatitis drugs and their therapeutic mechanism published until 2017. To 
provide data for conducting this review, the most up-to-date electronic journals 
including those indexed in the Pubmed, Elsevier, Institute for Scientific 
Information, Google Scholar and Scientific Information Database databases and 
various books, has been used. There are several plants for the treatment of viral 
diseases, including hepatitis B, which prevent or decrease infection via various 
mechanisms. Medicinal plants counteract viruses by various mechanisms, but 
most of them including Ganoderma lucidum and Oenanthe javanica inhibit the 
transcription of hepatitis B virus in hepatocytes. Most of action mechanism of 
medical plants exert an antiviral effect through inhibiting the transcription of 
HBV in hepatocytes; the need to study effective medicinal plants for treating 
different types of hepatitis, including hepatitis B and their action mechanisms 
have been intensified more than ever before, which makes this subject even 
more important. 
INTRODUCTION: The liver is a vital organ of 
the body, which is also considered to be the largest 
gland. The liver plays a major role in the 
physiological processes of the body, which 
includes metabolism, secretion and storage. 
Detoxification of various drugs and xenobiotics is 
performed in the liver. Bile secretion is another 
task of the liver that plays a very important role in 
digestion 
1, 2
. 
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Many toxic chemicals (certain antibiotics, 
chemotherapeutics, peroxidised oil, aflatoxin, 
carbon tetrachloride, acetaminophen, chlorinated 
hydrocarbons, etc.), food, alcohol, infections such 
as parasites, viruses, fungi or bacteria and also 
autoimmune disorders can cause liver diseases such 
as hepatitis, inflammatory liver disease, jaundice, 
hepatosis (non-inflammatory liver disease, cirrhosis 
(a digestive disorder that is the result of liver 
fibrosis), liver cancer, etc. 
1, 3
  
It is estimated that approximately 90% of hepatitis 
is of viral type, including hepatitis B, A, C, D (delta 
agents), E and G. Of these, hepatitis B often causes 
chronic liver disease and cirrhosis of the liver 
3
. 
Hepatitis B virus (HBV) is a virus from the 
Hepadnaviridae family 
4
. 
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HBV is the cause of hepatitis B, which is 
transmitted to the virus through infected blood and 
fluids of the body. Although acute hepatitis is 
spontaneously healed, treatment for chronic cases 
is recommended because of the likelihood of 
cirrhosis of the liver. The hepatitis B vaccination 
program is being implemented in endemic 
countries, which reduces the cases of infection with 
this virus 
5
. First, human beings were required to 
prepare the necessary medicines to cure their 
suffering and diseases from nature, especially 
plants. Chemical drugs are supplied worldwide for 
about 150 years.  
A comparison of the use of chemical and herbal 
drugs shows that chemical drugs, while having 
good effects, have side effects some of which last 
until the end of life, and even in some cases, are 
transmitted to the next generation, while the side 
effects of herbal drugs are comparatively lower and 
in many cases, they lead to very few or no 
complications. 
In the past decade, due to the problems that 
chemical drugs have caused for many people, the 
tendency to using and paying attention to plant-
derived medicinal products have increased. 
Another important issue is that for certain diseases, 
herbal remedies have better effects, and for some 
others, only herbal remedies are available 
6
. 
Due to the diversity of liver diseases, accurate 
diagnosis is very difficult and therefore a physician 
cannot do the exact and effective treatment for the 
disease. In most cases, treatment is symptomatic 
and supportive. On the other hand, current and 
modern drugs have high toxicity and it is therefore 
needed to replace these medications with high-
value drugs with comparatively lower toxicity 
1, 2
. 
Medicinal plants play an important role in 
maintaining health and survival of humans and 
animals. On the other hand, they contribute to the 
treatment of nontoxic liver disease 
7, 8, 9, 10
. The 
purpose of this article is to investigate and identify 
effective medicinal plants in the treatment of viral 
diseases, especially hepatitis B, and the involved 
therapeutic mechanisms. 
1. Medicinal Plants: Recently, a large proportion 
of the world population has turned to natural 
products to treat and prevent diseases. Influenced 
by this issue, pharmaceutical companies are 
developing new antimicrobial formulations that are 
derived from medicinal plants.  
Currently, phytotherapy is widely used across the 
world, especially in developed countries including 
some European countries and the United States 
11
. 
Approximately 45% of commercially available 
therapeutic products have been derived from 
medicinal plants or their derivatives 
12
. Recently, a 
worldwide upsurge in the preparation of medicinal 
plants and the isolation of their active compounds 
has emerged in health care 
13
. Many medicinal 
plants that are traditionally used have been reported 
to have antiviral properties, some of which are used 
to treat animals and people who suffer from viral 
infections 
14, 15, 16
. 
In a research on post - World War II antiviral 
agents in 1952 in Europe, a pharmaceutical 
company in England tested the antiviral activity of 
288 medicinal plants against influenza A virus in 
the egg embryo, showing that 12 of these plants 
prevented viral amplification 
17
. Over the past 40 
years, widespread programs around the world have 
begun to evaluate antiviral activity of medicinal 
plants in-vitro and in-vivo. Canadian researchers 
reported antiviral activity of grapes, apples, 
strawberries and other fruit juices against herpes 
simplex virus (HSV), poliovirus type 1, coxsackie 
virus B5 and Echovirus in the 1970s 
18, 19, 20, 21
.  
Antiviral activity of 100 British Columbian 
medicinal plants against seven viruses was 
investigated 
22
. At the tested concentrations of 
extract, 12 of the medicinal plants were found to 
have antiviral properties. The extracts of Rosa 
nutkana and Amelanchier alnifolia were very 
potent against enteric corona virus. Potentilla 
arguta root extract and Sambucus racemosa extract 
completely inhibit respiratory syncytial virus 
(RSV). It has been shown that the effect of 
Ipomopsis aggregata extract against the influenza 
type 3 virus is potent. 
Lomatium dissectum root extract completely 
inhibits the cytopathic effects of rotavirus. In 
addition, the extracts of Cardamine angulata, 
Conocephalum conicum, Lysichiton americanus, 
Polypodium glycyrrhiza and Verbascum thapsus 
have antiviral activity against herpes virus type 1. 
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The extracts of 40 different plant species used in 
the traditional medicine have antiviral properties 
against human cytomegalovirus (HCMV), Ross 
River virus (RRV), two RNA viruses, DNA virus 
and poliovirus type 123. The human rotavirus 
(HRV), RSV and influenza A virus are susceptible 
to Eleutherococcus senticosus root extract, while 
DNA viruses, HSV type 1 virus (HSV-1) and 
adenoviruses are not inhibited by its extract 
24
. 
Crude Sanicula europaea extract has antiviral 
properties against human parainfluenza virus type 
2, whereas its ethanol extract does not have such 
property 
25
. There are many medicinal plants with 
antiviral properties Table 1. 
TABLE 1: ANTIVIRAL MEDICINAL PLANTS 
Medicinal plant name Product type Viruses 
Melaleuca alternifolia 
26
 essential oils HSV-1(herpes simplex virus-1), 
HSV-2(herpes simplex virus-2) 
Santolina insularis 
27
 essential oils HSV-1 , HSV-2, herpes types 
Santalum album 
28
 essential oils HSV-1 
Sanicula europaea (L.) 
29
 water-soluble extract influenza 
Nigella sativa 
30
 black seed oil murine cytomegalovirus (MCMV) 
Eleutherococcus senticosus
 31
 liquid extract DNA viruses respiratory syncytial virus 
(RSV) adenovirus 
Rosa nutkana 
22
 extract enteric corona virus 
Amelanchier alnifolia 
22
 extract enteric corona virus 
Ipomopsis aggregate 
22
 extract parainfluenza virus type 3 
Lomatium dissectum 
22
 root extract rotavirus 
Potentilla arguta 
22
 root extract respiratory syncytial virus (RSV) 
Sambucus racemosa 
22
 branch tip extract respiratory syncytial virus (RSV) 
Cardamine angulata 
22
 extract herpes virus type 1 
Polypodium glycyrrhiza 
22
 extract herpes virus type 1 
Verbascum Thapsus 
22
 extract herpes virus type 1 
Conocephalum conicum 
22
 extract herpes virus type 1 
Lysichiton americanum 
22
 extract herpes virus type 1 
Dianella longifolia var. grandis (Liliaceae) 
23
 root extract poliovirus type 1 
Pterocaulon sphacelatum (Asteraceae) 
23
 extract poliovirus type 1 
Euphorbia australis (Euphorbiaceae) 
23
 extract human cytomegalovirus (HCMV) 
Scaevola spinescens (Goodeniaceae) 
23
 extract human cytomegalovirus (HCMV) 
Eremophila latrobei subsp. glabra 
(Myoporaceae) 
23
 
extract Ross River virus (RRV) 
Pittosporum phylliraeoides var. Microcarpa 
(Pittosporacea) 
23
 
extract Ross River virus (RRV) 
Sanicula europaea 
25
 crude extract Parainfluenza virus type 2 
Myrcianthes cisplatensis 
25
 extract RSV، adenovirus serotype7، HSV-1 
Azadirachta indica 
32
 leaf extract Smallpox, chicken pox, poxvirus, herpes 
viruses, poliomye litis 
Opuntia streptacantha 
33
 extract HSV, equine herpes virus, pseudorabies 
virus, influenza virus 
Bergenia ligulata 
34
 extract influenza virus, HSV 
Nerium indicum 
34
 ectract influenza virus, HSV 
Holoptelia integrifolia 
34
 ectract influenza virus, HSV 
 
2. Hepatitis B Virus: Hepatitis B is one of the 
most important global health issues that lead to 
high morbidity and mortality, and two factors have 
contributed to the epidemiology of this disease; 
vaccination programs and migration. Nearly 240 
million people worldwide have acquired chronic 
infection with this virus 
35, 36, 37, 38
. HBV-related 
mortality rates are more likely to be due to chronic 
infection, including liver cirrhosis and 
hepatocellular carcinoma (HCC).  
HCC is the most common cancer in the world, with 
chronic HBV infection responsible for 50 - 90% of 
cases of this cancer 
39
. HBV is a viral prototype of 
the Hepadnaviridae family that is double-stranded 
DNA genome 
4
 and is transcribed by the reverse 
transcription of the RNA pregenome 
4, 40
. HBV had 
eight genotypes from A to H with different 
virological characteristics and geographical 
distributions 
40, 41
. 
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More than 8% of the nucleotide sequences of each 
genotype are different from each other. 
Considering these conditions, the likelihood of 
recombination between genotypes, especially B/C 
and A/D, increases. Depending on the genotype of 
the virus, the DNA genome is composed of 3182-
3248 nucleotides 
42
. HBV is the cause of hepatitis 
B that is transmitted through the blood or the body 
fluids (secretions) that contain this virus. Although 
there is self-healing in acute hepatitis, treatment of 
chronic cases is recommended because of the 
possibility of cirrhosis of the liver.  
The hepatitis B vaccine program is implemented in 
endemic countries, which reduces the incidence of 
this virus 
5
. HBV primarily infects humans, but 
there are also reports regarding the detection of this 
infection in chimpanzee, Chacma baboons and tree 
shrews contamination 
43
. Most of the target cells of 
this virus are hepatocytes, but this virus is also 
found in other cells, such as those in the pancreas 
and kidney, bile duct lining cells and peripheral 
blood mononuclear cells 
43
. 
HBV is an enveloped virus with a diameter of 42 -
47 nm. The envelope consists of a small amount of 
lipid and three surface proteins including: Small 
(SHB), medium (MHB) and large (LHB), which 
comprise disulfide-linked hetero and homodimers. 
In the serum of the people with the infection, two 
types of particle are found: Small spherical 
particles with approximately 20 nm diameter and 
filamentous particles with approximately 20 nm 
diameter 
42
. The nucleocapsid is made up of 
nuclear protein that is composed of 185 - 188 
amino acids depending on the genome. The N-
terminal of 149 - 151 amino acids is responsible for 
the self assembly of nucleocapsids. This assembly 
has certain steps. The first step is the formation of 
homodimer links by disulfide bridges. The 
nucleocapsid contains poles that allow the 
nucleotide to bind during DNA synthesis. C-
terminal amino acids in this core protein play the 
role of genome packet 
44
. 
In the bloodstream of people with acute and 
chronic infections, high levels of HBV virions can 
be detected. Hepatocytes, which are the main target 
of this virus, are removed from the bloodstream by 
endothelial cells and kupffer cells, which are in 
direct contact with the sinusoids. Liver sinusoidal 
endothelial cells have a large cytoplasmic content 
of 50 - 100 nm in diameter. The virions of the 
bloodstream in the sinuses reach Dis space (the 
space between the endothelial cystic fibrosis and 
hepatocyte membrane). 
Virions bind hepatocyte surface by the LHB 
protein, or perhaps by a lipid envelope 
42, 43
. The 
nucleocapsid then releases into the cytoplasm and 
moves through the microtubules to the Micro-
tubules - Organizing Center (MTOC) near the 
nucleus. Access to nucleus through nuclear pores is 
accomplished through the mediation of polymerase 
and heat shock proteins 
42
. Then, transcription, 
translation steps and other steps are carried out.  
3. Anti - Hepatitis Medicinal Plants: Due to the 
diversity of liver diseases, accurate diagnosis is 
very difficult, so a physician cannot do the exact 
and effective treatment of the disease. On the other 
hand, the only drugs used to treat chronic infections 
are lamivudine, interferon α, HBV, and adefovir 
dipivoxil. Most of these available drugs inhibit 
reverse transcriptase activity. Modern and currently 
used drugs have high toxicity. In addition, the 
emergence of resistant mutants during long-term 
treatments is another major problem with modern 
medicines.  
It is, therefore, necessary to replace these 
medications with high-value ones with 
comparatively lower toxicity 
1, 2
. Many medicinal 
plants that are traditionally used have antiviral 
properties, and some of them are used to treat 
animals and people suffering from viral diseases 
45, 
46
. Medicinal plants have several phytochemicals 
that have potent antioxidant properties including 
alkaloids, carotenoids, saponins, flavonoids 
(isoflavones, flavonones, anthocyanins, catechins, 
flavones, isocatechins and quercetin), terpenoids, 
polyphenols (ellagic acid, gallic acid and tannins), 
vitamins (A, C, E and K), carotenoids, minerals 
(manganese, selenium, copper, chromium, zinc and 
iodine), polysaccharides, enzymes (superoxide 
dismutase, catalase and glutathione peroxidase), 
lignins, saponins, xanthones an pigments 
47, 48
.  
Antioxidants treat various diseases by protecting 
cells against free radical-induced damage 
47
. 
Several medicinal plants are used to treat hepatitis 
or hepatotoxicity, and some of them have anti-HBV 
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activity. For example, Curcuma longa Linn. has 
antiviral properties against HBV, which inhibits the 
production of the constituents of HBV and HBV 
RNA in hepatocytes. The extract of this plant is 
indeed an inhibitor of transcription of HBV.  
In addition, studies have shown that the antiviral 
activity of this plant is associated with an increase 
in the intracellular accumulation of the P53 protein, 
which is due to increased transcription of the P53 
protein gene 
49
. Another plant is Ganoderma 
lucidum. Studies have shown that ganoderic acid 
isolated from this medicinal plant inhibits HBV 
transcription in the HepG2215 hepatocytes, 
resulting in an antiviral activity against HBV 
50
.  
TABLE 2: ANTIHEPATITIS MEDICAL PLANTS 
Family Medicinal plant name Hepatitis 
Zingiberaceae Curcuma longa Linn. Hepatitis B Virus 
49
 
Ganodermataceae Ganoderma lucidum Hepatitis B Virus 
50
 
Euphorbiaceae Phyllanthus amarus or Phyllanthus niruri Hepatitis B Virus 
54, 55, 56, 57
 
Euphorbiaceae Phyllanthusanus Hepatitis B Virus 
55, 56, 57, 58
 
Acanthaceae Acanthus ilicifolius L Hepatitis B Virus 
52, 53
 
Apiaceae Oenanthe javanica Hepatitis B Virus 
59, 60
 
Gentianaceae Swertia patens Hepatitis B Virus 
61, 62
 
Gentianaceae Swertia chirayita Hepatitis B Virus 
61, 62
 
Urticaceae Boehmeria nivea Hepatitis B Virus 
63
 
Rutaceae Citrus Sinensis Hepatitis C Virus
 65
 
Crassulaceae Rhodiola kirilowii Hepatitis C Virus 
66
 
Mimosoideae Acacia nilotica Hepatitis C Virus 
64
 
Burseraceae Boswellia carterii Hepatitis C Virus 
64
 
Myrsinaceae Embelia schimperi Hepatitis C Virus 
64
 
Fagaceae Quercus infectoria Hepatitis C Virus 
64
 
Apiaceae Trachyspermum ammi Hepatitis C Virus 
64
 
Piperaceae Piper cubeba Hepatitis C Virus 
64
 
Myrtaceae Syzygium aromaticum Hepatitis C Virus 
64
 
Zingiberaceae Zingiber officinale Hepatitis C Virus 
67
 
Asteraceae Silybum marianum Hepatitis C Virus 
67
  
Saxifragaceae Saxifraga melanocentra Hepatitis C Virus 
68
 
Lamiaceae Mentha longifolia Hepatitis A Virus 
69
 
Lamiaceae Ocimum basilicum Hepatitis A Virus
 69 
 
Asteraceae Taraxacum Officinalis Hepatitis 
70
 
Brassicaceae Lepidium sativum Hepatitis 
71
 
Fabaceae Trigonella foenum graecum Hepatitis 
72
 
Meliaceae Azadirachta indica Hepatitis 
73
  
Fabaceae Glycyrrhiza glabra Hepatitis 
74
 
Euphorbiaceae Jatropha curcas Linnaeus Hepatitis 
75
 
Asteraceae Cynara scolymus Hepatitis 
76
 
Asteraceae Matricaria chamomilla Hepatitis
 77
 
Fabaceae Cassia fistula Hepatitis 
78
 
Marchantiaceae Marchantia thallus Hepatitis 
79
 
Asteraceae Silybum marianum Hepatitis 
80
 
Fabaceae Sophora flavescens Hepatitis
 81
 
Salicaceae Flacourtia indica Governor’s Plum Hepatitis 82 
Rubiaceae Morinda citrifolia Hepatitis 
83
 
 
Clinical studies have indicated that phylantus 
species have positive effects on HBsAg in the 
clearance of serum from HBV carriers 
51
. For 
example, P. amarus (L.) is an inhibitor of HBV 
polymerase activity and mRNA transcription 
47
. 
Another plant that has antiviral activity against 
hepatitis is Oenanthe javanica. Studies have shown 
that this plant is helpful to treat HBV-induced 
infections by inhibiting transcription of HBV in 
hepatocytes 
49
. Acanthus ilicifolius L. reduces 
HBV-induced liver damage by reducing 
transaminase 
52, 53
. Other plants also have anti-
hepatitis properties. In general, there is not enough 
information on the action mechanisms of medicinal 
plants on HBV, although there are effective natural 
products against HBV and the resulting infections 
Table 2. 
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CONCLUSION: Recently, due to the many side 
effects and the presence of medicinal residues of 
the chemical drugs for the treatment of viral 
diseases, especially hepatitis, attention has been 
paid to medicinal plant-derived products has 
increased.  
It is, therefore, necessary, more than ever before, to 
address and study effective medicinal plants to treat 
different types of hepatitis, including hepatitis B, 
and their action mechanisms, which makes this 
subject even more important.  
The action mechanism of a number of anti-hepatitis 
B drugs has been understood. Most of them exert 
an antiviral effect through inhibiting the 
transcription of HBV in hepatocytes; however, the 
action mechanism of many plants remains 
unknown and needs to be further studied.  It should 
be noted that usually phenolic compounds in 
medicinal plants possess antimicrobial activities. 
Hence, other plants which have these compounds 
84, 85
 may possess anti-hepatitis activities, too, 
which worth examining. 
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